Modulation of steroid hormone receptor activity

Progress in Brain Research

Volumn 181, Issue C, 2010, Pages 153-176

  Stanišíc, Vladimir ^a   Lonard, David M ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coactivator; Hormone mediated transcription; Post translational modifications; Steroid hormone; Steroid hormone receptor; Steroid receptor degradation

Indexed keywords

17 HYDROXYPREGNENOLONE; ALDOSTERONE; ANDROGEN; ANDROGEN RECEPTOR; DNA METHYLTRANSFERASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FACTOR AF2; GESTAGEN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MESSENGER RNA; MINERALOCORTICOID; PREGNENOLONE; RNA POLYMERASE II; STEROID RECEPTOR; TESTOSTERONE; VITAMIN D RECEPTOR; HORMONE; MULTIPROTEIN COMPLEX; STEROID;

3' UNTRANSLATED REGION; ARTICLE; HORMONE STRUCTURE; HUMAN; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RNA STABILITY; TRANSLATION REGULATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HORMONES; HUMANS; MOLECULAR STRUCTURE; MULTIPROTEIN COMPLEXES; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RECEPTORS, STEROID; RNA STABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROIDS;

EID: 77955500692     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)81009-6     Document Type: Article

References (177)

1. Abdel-Hafiz, H., Dudevoir, M. L., & Horwitz, K. B. (2009). Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation. Journal of Biological Chemistry, 284, 9099-9108.
2. Abdel-Hafiz, H., Takimoto, G. S., Tung, L., & Horwitz, K. B. (2002). The inhibitory function in human progesterone receptor n termini binds SUMO-1 protein to regulate autoinhibition and transrepression. Journal of Biological Chemistry, 277, 33950-33956.
3. Adams, B. D., Furneaux, H., & White, B. A. (2007). The microribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-{alpha} (ER{alpha}) and represses ER{alpha} messenger RNA and protein expression in breast cancer cell lines. Molecular Endocrinology, 21, 1132-1147.
4. Adzic, M., Djordjevic, J., Djordjevic, A., Niciforovic, A., Demonacos, C., Radojcic, M., et al. (2009). Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in wistar rat brain. Journal of Endocrinology, 202, 87-97.
5. Alarid, E. T., Bakopoulos, N., & Solodin, N. (1999). Proteasome-mediated proteolysis of estrogen receptor: A novel component in autologous down-regulation. Molecular Endocrinology, 13, 1522-1534.
6. Almlof, T., Wright, A. P., & Gustafsson, J. A. (1995). Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. The Journal of Biological Chemistry, 270, 17535-17540.
7. Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., et al. (1997). AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science, 277, 965-968.
8. Ballinger, C. A., Connell, P., Wu, Y., Hu, Z., Thompson, L. J., Yin, L.-Y., et al. (1999). Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Molecular and Cellular Biology, 19, 4535-4545.
9. Bauer, U. M., Daujat, S., Nielsen, S. J., Nightingale, K., & Kouzarides, T. (2002). Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Reports, 3, 39-44.
10. Bedford, M. T. & Richard, S. (2005). Arginine methylation: An emerging regulator of protein function. Molecular Cell, 18, 263-272.
11. Bourguet, W., Germain, P., & Gronemeyer, H. (2000). Nuclear receptor ligand-binding domains: Three-dimensional structures, molecular interactions and pharmacological implications. Trends in Pharmacological Sciences, 21, 381-388.
12. Brady, L. S., Whitfield, Jr., Fox, H. J., Gold, R. J., & Herkenham, P. W. M. (1991) Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. Journal of Clinical Investigation 87, 831-837.
13. Breslin, M. B., Geng, C.-D., & Vedeckis, W. V. (2001). Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids. Molecular Endocrinology, 15, 1381-1395.
14. Burgdorf, S., Leister, P., & Scheidtmann, K. H. (2004). TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. Journal of Biological Chemistry, 279, 17524-17534.
15. Castles, C. G., Oesterreich, S., Hansen, R., & Fuqua, S. A.W. (1997). Auto-regulation of the estrogen receptor promoter. The Journal of Steroid Biochemistry and Molecular Biology, 62, 155-163.
16. Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J., et al. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO Journal, 14, 3741-3751.
17. Chen, W., Dang, T., Blind, R. D., Wang, Z., Cavasotto, C. N., Hittelman, A. B., et al. (2008). Glucocorticoid receptor phosphorylation differentially affects target gene expression. Molecular Endocrinology, 22, 1754-1766.
18. Chen,H.,Lin, R. J., Schiltz, R.L.,Chakravarti,D., Nash,A., Nagy, L., et al. (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell, 90, 569-580.
19. Chen, D. S., Washbrook, E., Sarwar, N., Bates, G. J., Pace, P. E., Thirunuvakkarasu, V., et al. (2002). Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene, 21, 4921-4931.
20. Chiba, H., Muramatsu, M., Nomoto, A., & Kato, H. (1994). Two human homologues of saccharomyces cerevisiae SWI2/ SNF2 and drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Research, 22, 1815-1820.
21. Cho, S., Kagan, B. L., Blackford, J. A., Jr., Szapary, D., & Simons, S. S., Jr. (2005). Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and ubc9.
22. Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M., & Zaret, K. S. (2002). Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Molecular Cell, 9, 279-289.
23. Cui, Y., Zhang, M., Pestell, R., Curran, E. M., Welshons,W. V., & Fuqua, S. A.W. (2004). Phosphorylation of estrogen receptor {alpha} blocks its acetylation and regulates estrogen sensitivity. Cancer Research, 64, 9199-9208.
24. Demarest, S. J., Martinez-Yamout, M., Chung, J., Chen, H., Xu, W., Dyson, H. J., et al. (2002). Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature, 415, 549-553.
25. DiRenzo, J., Shang, Y., Phelan, M., Sif, S., Myers, M., Kingston, R., et al. (2000). BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Molecular and Cellular Biology, 20, 7541-7549.
26. Donaghue, C., Westley, B. R., & May, F. E.B. (1999). Selective promoter usage of the human estrogen receptor-{alpha} gene and its regulation by estrogen. Molecular Endocrinology, 13, 1934-1950.
27. Duma, D., Jewell, C. M., & Cidlowski, J. A. (2006). Multiple glucocorticoid receptor isoforms and mechanisms of posttranslational modification. The Journal of Steroid Biochemistry and Molecular Biology, 102, 11-21.
28. Eakin, C. M., MacCoss, M. J., Finney, G. L., & Klevit, R. E. (2007). Estrogen receptor I+ is a putative substrate for the BRCA1 ubiquitin ligase. Proceedings of the National Academy of Sciences, 104, 5794-5799.
29. Eeckhoute, J. R.M., Carroll, J. S., Geistlinger, T. R., Torres-Arzayus, M. I., & Brown, M. (2006). A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes and Development, 20, 2513-2526.
30. Eeckhoute, J., Keeton, E. K., Lupien, M., Krum, S. A., Carroll, J. S., & Brown, M. (2007). Positive cross-regulatory loop ties GATA-3 to estrogen receptor {alpha} expression in breast cancer. Cancer Research, 67, 6477-6483.
31. Evans, R. (1988a). The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
32. Evans, R. M. (1988b). The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
33. Evans, R. M. (2005). The nuclear receptor superfamily: A rosetta stone for physiology. Molecular Endocrinology, 19, 1429-1438.
34. Fan, M., Bigsby, R. M., & Nephew, K. P. (2003). The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-{alpha} and essential for the antiproliferative activity of ICI 182,780 in ER{alpha}-positive breast cancer cells. Molecular Endocrinology, 17, 356-365.
35. Fan, M., Park, A., & Nephew, K. P. (2005). CHIP (carboxyl terminus of hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-{alpha}. Molecular Endocrinology, 19, 2901-2914.
36. Faus, H. & Haendler, B. (2006a). Post-translational modifications of steroid receptors. Biomedicine and Pharmacotherapy, 60, 520-528.
37. Faus, H. & Haendler, B. (2006b). Post-translational modifications of steroid receptors. Biomedecine and Pharmacotherapy, 60, 520-528.
38. Flouriot, G., Griffin, C., Kenealy, M., Sonntag-Buck, V., & Gannon, F. (1998). Differentially expressed messenger RNA isoforms of the human estrogen receptor-{alpha} gene are generated by alternative splicing and promoter usage. Molecular Endocrinology, 12, 1939-1954.
39. Fu, M., Rao, M., Wang, C., Sakamaki, T., Wang, J., Di Vizio, D., et al. (2003). Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Molecular and Cellular Biology, 23, 8563-8575.
40. Fu, M., Wang, C., Reutens, A. T., Wang, J., Angeletti, R. H., Siconolfi-Baez, L., et al. (2000). P300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. Journal of Biological Chemistry, 275, 20853-20860.
41. Galliher-Beckley, A. J., Williams, J. G., Collins, J. B., & Cidlowski, J. A. (2008). Glycogen synthase kinase 3{beta}-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Molecular and Cellular Biology, 28, 7309-7322.
42. Garcia-Pedrero, J. M., Kiskinis, E., Parker, M. G., & Belandia, B. (2006). The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. The Journal of Biological Chemistry, 281, 22656-22664.
43. Gaughan, L., Logan, I. R., Cook, S., Neal, D. E., & Robson, C. N. (2002). Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. Journal of Biological Chemistry, 277, 25904-25913.
44. Gioeli, D., Black, B. E., Gordon, V., Spencer, A., Kesler, C. T., Eblen, S. T., et al. (2006). Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Molecular Endocrinology, 20, 503-515.
45. Gong, J., Zhu, J., Goodman, O. B., Pestell, R. G., Schlegel, P. N., Nanus, D. M., & Shen, R. (2006). Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene. 25, 2011-2021.
46. Gorski, J. & Nicolette, J. A. (1963). Early estrogen effects on newly synthesized RNA and phospholipid in subcellular fractions of rat uteri. Archives of Biochemistry and Biophysics, 103, 418-423.
47. Gottlicher, M., Heck, S., Doucas, V., Wade, E., Kullmann, M., Cato, A. C., et al. (1996). Interaction of the ubc9 human homologue with c-Jun and with the glucocorticoid receptor. Steroids, 61, 257-262.
48. Grandien, K., Backdahl, M., Ljunggren, O., Gustafsson, J., & Berkenstam, A. (1995). Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology, 136, 2223-2229.
49. Grandien, K. F.H., Berkenstam, A., Nilsson, S., & Gustafsson, J.-A. (1993). Localization of DNase i hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters. Journal of Molecular Endocrinology, 10, 269-277.
50. Green, K. A. & Carroll, J. S. (2007). Oestrogen-receptormediated transcription and the influence of co-factors and chromatin state. Nature Reviews Cancer, 7, 713-722.
51. Green, S. & Chambon, P. (1988). Nuclear receptors enhance our understanding of transcription regulation. Trends in Genetics, 4, 309-314.
52. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P. & Chambon, P. (1986). Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A. Nature, 320, 134-139.
53. Greene, G. L., Waterfield, G. P., Baker, M., Hort, A., & Shine, Y. (1986). Sequence and expression of human estrogen receptor complementary DNA. Science, 231, 1150-1154.
54. Griffin, C., Flouriot, G., Sonntag-Buck, V., Nestor, P., & Gannon, F. (1998). Identification of novel chicken estrogen receptor-{alpha} messenger ribonucleic acid isoforms generated by alternative splicing and promoter usage. Endocrinology, 139, 4614-4625.
55. Gustafsson, J. A., Carlstedt-Duke, J., Wrange, O., Okret, S., & Wikstr̈om, A. C. (1986). Functional analysis of the purified glucocorticoid receptor. The Journal of Steroid Biochemistry, 24, 63-68.
56. Guyton, A. C. & Hall, J. E. (2006). Textbook of medical physiology. Philadelphia: Elsevier Saunders.
57. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994). Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science, 264, 1455-1458.
58. Halkidou, K., Gnanapragasam, V.J., Mehta, P.B., Logan, I.R., Brady, M.E., Cook, S., et al. (2003). Expression of tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene, 22, 2466-2477.
59. He, B., Bai, S., Hnat, A. T., Kalman, R. I., Minges, J. T., Patterson, C., et al. (2004). An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the hsp70-interacting protein (CHIP). Journal of Biological Chemistry, 279, 30643-30653.
60. Hershko, A. (1996). Lessons from the discovery ofthe ubiquitin system. Trends in Biochemical Sciences, 21, 445-449.
61. Hershko, A. & Ciechanover, A. (1998). The ubiquitin system. Annual Review of Biochemistry, 67, 425-479.
62. Hollenberg, S. M., Ong, W. C., Cerelli, E. S., Oro, G., Lebo, A., Thompson, R., et al. (1985). Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641.
63. Hong, H., Kohli, K., Garabedian, M., & Stallcup, M. (1997). GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin d receptors. Molecular and Cellular Biology, 17, 2735-2744.
64. Ichinose, H., Garnier, J.-M., Chambon, P., & Losson, R. (1997). Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene, 188, 95-100.
65. Imhof, M. & McDonnell, D. (1996). Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Molecular and Cellular Biology, 16, 2594-2605.
66. Ing, N. H. (2005). Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs. Biology of Reproduction, 72, 1290-1296.
67. Ing, N. H., Massuto, D. A., & Jaeger, L. A. (2008). Estradiol up-regulates AUF1p45 binding to stabilizing regions within the 3'-untranslated region of estrogen receptor {alpha} mRNA. The Journal of Biological Chemistry, 283, 1764-1772.
68. Ismail, A. & Nawaz, Z. (2005). Nuclear hormone receptor degradation and gene transcription: An update. IUBMB Life, 57, 483-490.
69. Ismaili, N. & Garabedian, M. J. (2004a). Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Sciences, 1024, 86-101.
70. Ismaili, N. & Garabedian, M. J. (2004b). Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Sciences, 1024, 86-101.
71. Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., et al. (2006). Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-{kappa}b suppression. The Journal of Experimental Medicine, 203, 7-13.
72. Jacobson, H. I. & Jensen, E. V. (1962). Basic guides to the mechanism of estrogen action. Recent Progress in Hormone Research, 18, 387-414.
73. Jensen, E. V. (1962). On the mechanism of estrogen action. Perspectives in Biology and Medicine, 6, 47-59.
74. Jensen, E. V. & DeSombre, E. R. (1973). Estrogen-receptor interaction: Estrogenic hormones effect transformation of specific receptor proteins to a biochemically functional form. Science, 182(4108), 126-134.
75. Jiang, J., Sarwar, N., Peston, D., Kulinskaya, E., Shousha, S., Coombes, R. C., et al. (2007). Phosphorylation of estrogen receptor-alpha at ser(167) is indicative of longer disease-free and overall survival in breast cancer patients. Clinical Cancer Research, 13, 5769-5776.
76. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., et al. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85, 403-414.
77. Kassabov, S. R., Zhang, B., Persinger, J., & Bartholomew, B. (2003). SWI/SNF unwraps, slides, and rewraps the nucleosome. Molecular Cell, 11, 391-403.
78. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., et al. (1990). Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms a and B. The EMBO Journal, 9, 1603-1614.
79. Keaveney, M., Parker, M. G., & Gannon, F. (1993). Identification of a functional role for the 3' region of the human oestrogen receptor gene. Journal of Molecular Endocrinology, 10, 143-152.
80. Kenealy, M.-R., Flouriot, G., Sonntag-Buck, V., Dandekar, T., Brand, H., & Gannon, F. (2000). The 30-untranslated region of the human estrogen receptor {alpha} gene mediates rapid messenger ribonucleic acid turnover. Endocrinology, 141, 2805-2813.
81. Khissiin, A. E. & Leclercq, G. (1999). Implication of proteasome in estrogen receptor degradation. FEBS Letters, 448, 160-166.
82. Kim, M. Y., Hsiao, S. J., & Kraus, W. L. (2001). A role for coactivators and histone acetylation in estrogen receptor alpha-mediated transcription initiation. EMBO Journal, 20, 6084-6094.
83. Kim, M. Y., Woo, E. M., Chong, Y. T.E., Homenko, D. R., & Kraus, W. L. (2006). Acetylation of estrogen receptor {alpha} by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Molecular Endocrinology, 20, 1479-1493.
84. Klinge, C. M. (2000). Estrogen receptor interaction with coactivators and co-repressors[small star, filled]. Steroids, 65, 227-251.
85. Kobayashi, Y., Kitamoto, T., Masuhiro, Y., Watanabe, M., Kase, T., Metzger, D., et al. (2000). P300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains. The Journal of Biological Chemistry, 275, 15645-15651.
86. Korkmaz, C., Fronsdal, K., Zhang, Y., Lorenzo, P., & Saatcioglu, F. (2004). Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation-rescue of transcriptionally compromised mutants. Journal of Endocrinology, 182, 377-389.
87. Kos, M., Reid, G., Denger, S., & Gannon, F. (2001). Minireview: Genomic organization of the human ERalpha gene promoter region. Molecular Endocrinology, 15, 2057-2063.
88. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D., & Werb, Z. (2006). GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell, 127, 1041-1055.
89. Krstic, M. D., Rogatsky, I., Yamamoto, K. R., & Garabedian, M. J. (1997). Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Molecular and Cellular Biology, 17, 3947-3954.
90. Lange, C. A., Shen, T., & Horwitz, K. B. (2000). Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26s proteasome. Proceedings of the National Academy of Sciences of the United States of America, 97, 1032-1037.
91. Lannigan, D. A. (2003). Estrogen receptor phosphorylation. Steroids, 68, 1-9.
92. Le Douarin, B., Zechel, C., Garnier, J. M., Lutz, Y., Tora, L., Pierrat, B., et al. (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO Journal, 14, 2020-2033.
93. LeDrean, Y.,Mincheneau, N., LeGoff, P.,& Michel,D. (2002). Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology, 143, 3482-3489.
94. Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A., & Moore, D. D. (1995). Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature, 374, 91-94.
95. Li, L., Li, Z., Howley, P. M., & Sacks, D. B. (2006). E6AP and calmodulin reciprocally regulate estrogen receptor stability. The Journal of Biological Chemistry, 281, 1978-1985.
96. Likhite, V. S., Stossi, F., Kim, K., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2006). Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Molecular Endocrinology, 20, 3120-3132.
97. Listwak, S. J., Gold, P. W., & Whitfield, H. J. (1996). The human mineralocorticoid receptor gene promoter: Its structure and expression. The Journal of Steroid Biochemistry and Molecular Biology, 58, 495-506.
98. Liu, G., Schwartz, J. A., & Brooks, S. C. (2000). Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Research, 60, 1810-1814.
99. Liu, W.-H., Yeh, S.-H., Lu, C.-C., Yu, S.-L., Chen, H.-Y., Lin, C.-Y., et al. (2009). MicroRNA-18a prevents estrogen receptor-[alpha] expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology, 136, 683-693.
100. Lonard, D. M., Nawaz, Z., Smith, C. L., & O'Malley, B. W. (2000). The 26s proteasome is required for estrogen receptoralpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Molecular Cell, 5, 939-948.
101. Lonard, D. M. & O'Malley, B. W. (2007). Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Molecular Cell 27, 691-700.
102. Lonard, D. M. & O'Malley, B. W. (2008a). Gene transcription: Two worlds merged. Nature, 452, 946-947.
103. Lonard, D. M. & O'Malley, B. W. (2008b). SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: Is there enough coactivator to go around in cells? Science Signaling, 1, pe16.
104. Lu, N. Z. & Cidlowski, J. A. (2006). Glucocorticoid receptor isoforms generate transcription specificity. Trends in Cell Biology, 16, 301-307.
105. Ma, H., Baumann, C. T., Li, H. W., Strahl, B. D., Rice, R., Jelinek, M. A., et al. (2001). Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Current Biology, 11, 1981-1985.
106. Ma, Y., Katiyar, P., Jones, L. P., Fan, S., Zhang, Y., Furth, P. A., et al. (2006). The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Molecular Endocrinology, 20, 14-34.
107. Mallepell, S., Krust, A. E., Chambon, P., & Brisken, C. (2006). Paracrine signaling through the epithelial estrogen receptor I+ is required for proliferation and morphogenesis in the mammary gland. Proceedings of the National Academy of Sciences of the United States of America, 103, 2196-2201.
108. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. (1995). The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
109. Martinez-Balbas, M. A., Bannister, A. J., Martin, K., Haus-Seuffert, P., Meisterernst, M., & Kouzarides, T. (1998). The acetyltransferase activity of CBP stimulates transcription. EMBO Journal, 17, 2886-2893.
110. McKenna, N. J., Xu, J., Nawaz, Z., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (1999). Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. The Journal of Steroid Biochemistry and Molecular Biology, 69, 3-12.
111. Means, A. R., Comstock, J. P., Rosenfeld, G. C., & O'Malley, B. W. (1972). Ovalbumin messenger RNA of chick oviduct: Partial characterization, estrogen dependence, and translation in vitro. Proceedings of the National Academy of Sciences of the United States of America, 69, 1146-1150.
112. Metivier, R., Penot, G., Hubner, M. R., Reid, G., Brand, H., Kos, M., et al. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
113. Miesfeld, R.,Okret, S.,Wikstrom,A. C.,Wrange, O.,Gustafsson, J. A., & Yamamoto, K. R. (1984). Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature, 312, 779-781.
114. Miesfeld, R., Rusconi, S., Godowski, P. J., Maler, B. A., Sample, O., Wikstr̈om, A.-C., et al. (1986). Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell, 46, 389-399.
115. Mukhopadhyay, N. K., Kim, J., Cinar, B., Ramachandran, A., Hager, M. H., Di Vizio, D., et al. (2009). Heterogeneous nuclear ribonucleoprotein k is a novel regulator of androgen receptor translation. Cancer Research, 69, 2210-2218.
116. Murphy, L. C., Weitsman, G. E., Skliris, G. P., Teh, E. M., Li, L., Peng, B., et al. (2006). Potential role of estrogen receptor ot (ER alpha) phosphorylated at Serine(118) in human breast cancer in vivo. The Journal of Steroid Biochemistry and Molecular Biology, 102, Issues 1-5, pp. 139-146.
117. Nader, N., Chrousos, G. P., & Kino, T. (2009). Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: Potential physiological implications. The FASEB Journal, 23, 1572-1583.
118. Nagy, L. & Schwabe, J. W.R. (2004). Mechanism of the nuclear receptor molecular switch. Trends in Biochemical Sciences, 29, 317-324.
119. Nandi, D., Tahiliani, P., Kumar, A., & Chandu, D. (2006). The ubiquitin-proteasome system. Journal of Biosciences, 31, 137-155.
120. Nardulli, A. M. & Katzellenbogen, B. S. (1988). Progesterone receptor regulation in T47D human breast cancer cells: Analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology, 122, 1532-1540.
121. Nawaz, Z., Lonard, D. M., Dennis, A. P., Smith, C. L., & O'Malley, B. W. (1999a). Proteasome-dependent degradation of the human estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America, 96, 1858-1862.
122. Nawaz, Z., Lonard, D. M., Smith, C. L., Lev-Lehman, E., Tsai, S. Y., Tsai, M.-J., et al. (1999b). The angelman syndromeassociated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Molecular and Cellular Biology, 19, 1182-1189.
123. Nishida, T. & Yasuda, H. (2002). PIAS1 and PIASxI+ function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. Journal of Biological Chemistry, 277, 41311-41317.
124. Nobukuni, Y., Smith, C. L., Hager, G. L., & Detera-Wadleigh, S. D. (2002). Characterization of the human glucocorticoid receptor promoter. Biochemistry, 34, 8207-8214.
125. Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science, 270, 1354-1357.
126. O'Malley, B. W. & Means, A. R. (1974). Female steroid hormones and target cell nuclei: The effects of steroid hormones on target cell nuclei are of major importance in the induction of new cell functions. Science, 183, 610-620.
127. Pandey, D. P. & Picard, D. (2009). MiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor {alpha} mRNA. Molecular and Cellular Biology, 29(13), 3783-3790.
128. Pike, A. C.W. (2006). Lessons learnt from structural studies of the oestrogen receptor. Best Practice and Research Clinical Endocrinology and Metabolism, 20, 1-14.
129. Pinzone, J. J., Stevenson, H., Strobl, J. S., & Berg, P. E. (2004). Molecular and cellular determinants of estrogen receptor alpha expression. Molecular and Cellular Biology, 24, 4605-4612.
130. Ponglikitmongkol, S. G. & Chambon, P. (1988). Genomic organization of the human oestrogen receptor gene. The EMBO Journal, 7, 3385-3388.
131. Poukka, H., Aarnisalo, P., Karvonen, U., & Palvimo, J. (1999). Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. Journal of Biological Chemistry, 274, 19441-19446.
132. Poukka, H., Karvonen, U., Janne, O. A., & Palvimo, J. J. (2000). Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proceedings of the National Academy of Sciences of the United States of America, 97, 14145-14150.
133. Qi, C., Chang, J., Zhu, Y. W., Yeldandi, A. V., Rao, S. M., & Zhu, Y. J. (2002). Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. Journal of Biological Chemistry, 277, 28624-28630.
134. Qiu, M. & Lange, C. A. (2003). MAP kinases couple multiple functions of human progesterone receptors: Degradation, transcriptional synergy, and nuclear association. The Journal of Steroid Biochemistry and Molecular Biology, 85, 147-157.
135. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., et al. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Molecular Cell, 11, 695-707.
136. Saji, S., Okumura, N., Eguchi, H., Nakashima, S., Suzuki, A., Toi, M., et al. (2001). MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochemical and Biophysical Research Communications, 281, 259-265.
137. Santos-Rosa, H., Valls, E., Kouzarides, T., & Martinez-Balbas, M. (2003). Mechanisms of P/CAF auto-acetylation. Nucleic Acids Research, 31, 4285-4292.
138. Schaaf, M. J.M. & Cidlowski, J. A. (2002). AUUUA motifs in the 3'UTR of human glucocorticoid receptor [alpha] and [beta] mRNA destabilize mRNA and decrease receptor protein expression. Steroids, 67, 627-636.
139. Schiltz, R. L., Mizzen, C. A., Vassilev, A., Cook, R. G., Allis, C. D., & Nakatani, Y. (1999). Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. The Journal of Biological Chemistry, 274, 1189-1192.
140. Schurter, B. T., Koh, S. S., Chen, D., Bunick, G. J., Harp, J. M., Hanson, B. L., et al. (2001). Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry, 40, 5747-5756.
141. Sentis, S., Le Romancer, M., Bianchin, C., Rostan, M.-C., & Corbo, L. (2005). Sumoylation of the estrogen receptor {alpha} hinge region regulates its transcriptional activity. Molecular Endocrinology, 19, 2671-2684.
142. Sharma, M., Li, X., Wang, Y., Zarnegar, M., Huang, C.-Y., Palvimo, J. J., et al. (2003). HZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. The EMBO Journal, 22, 6101-6114.
143. Spelsberg, T. C., Steggles, A. W., Chytil, F., & O'Malley, B. W. (1972). Progesterone-binding components of chick oviduct. V. Exchange of progesterone-binding capacity from target to nontarget tissue chromatins. The Journal of Biological Chemistry, 247, 1368-1374.
144. Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., et al. (1997). Steroid receptor coactivator-1 is a histone acetyltransferase. Nature, 389, 194-198.
145. Stanisic, V., Malovannaya, A., Qin, J., Lonard, D. M., & O'Malley, B. W. (2009). OTU-domain containing ubiquitin aldehyde binding protein 1 (OTUB1) deubiquitinates estrogen receptor -alpha (ERalpha) and affects ERalpha transcriptional activity. The Journal of Biological Chemistry, 284, 16135-16145. M109.007484.
146. Stenoien, D. L., Patel, K., Mancini, M. G., Dutertre, M., Smith, C. L., O'Malley, B. W., et al. (2001). FRAP reveals that mobility of oestrogen receptor-[alpha] is ligand-and proteasome-dependent. Nature Cell Biology, 3, 15-23.
147. Strahl, B. D., Briggs, S. D., Brame, C. J., Caldwell, J. A., Koh, S. S., Ma, H., et al. (2001). Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Current Biology, 11, 996-1000.
148. Subramanian, K., Jia, D., Kapoor-Vazirani, P., Powell, D. R., Collins, R. E., Sharma, D., et al. (2008). Regulation of estrogen receptor [alpha] by the SET7 lysine methyltransferase. Molecular Cell, 30, 336-347.
149. Tateishi, Y., Kawabe, Y., Chiba, T., Murata, S., Ichikawa, K., Murayama, A., et al. (2004). Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. The EMBO Journal, 23, 4813-4823.
150. Tateishi, Y., Sonoo, R., Sekiya, Y.-I., Sunahara, N., Kawano, M., Wayama,M., et al. (2006). Turning off estrogen receptor {beta}-mediated transcription requires estrogen-dependent receptor proteolysis. Molecular and Cellular Biology, 26, 7966-7976.
151. Thomas, M., Dadgar, N., Aphale, A., Harrell, J. M., Kunkel, R., Pratt, W. B., et al. (2004). Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation Similar To expanded glutamine tracts. Journal of Biological Chemistry, 279, 8389-8395.
152. Thomas, R. S., Sarwar, N., Phoenix, F., Coombes, R. C., & Ali, S. (2008). Phosphorylation at serines 104 and 106 by erk1/2 MAPK is important for estrogen receptor-alpha activity. Journal of Molecular Endocrinology, 40, 173-184.
153. Thorat, M. A., Marchio, C., Morimiya, A., Savage, K., Nakshatri, H., Reis-Filho, J. S., et al. (2008). Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. Journal of Clinical Pathology, 61, 327-332.
154. Toft, D. & Gorski, J. (1966). A receptor molecule for estrogens: Isolation from the rat uterus and preliminary characterization. Proceedings of the National Academy of Sciences of the United States of America, 55, 1574-1581.
155. Torchia, J., Glass, C., & Rosenfeld, M. G. (1998). Co-activators and co-repressors in the integration of transcriptional responses. Current Opinion in Cell Biology, 10, 373-383.
156. Treilleux, I., Peloux, N., Brown, M., & Sergeant, A. (1997). Human estrogen receptor (ER) gene promoter-P1: Estradiol-independent activity and estradiol inducibility in ERp and ER-cells. Molecular Endocrinology, 11, 1319-1331.
157. Tsai, S.-Y., Tsai, M.-J., Schwartz, R., Kalimi, M., Clark, J. H., & O'Malley, B. W. (1975). Effects of estrogen on gene expression in chick oviduct: Nuclear receptor levels and initiation of transcription. Proceedings of the National Academy of Sciences of the United States of America, 72, 4228-4232.
158. Verma, S., Ismail, A., Gao, X., Fu, G., Li, X., O'Malley, B. W., et al. (2004). The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Molecular and Cellular Biology, 24, 8716-8726.
159. Voet, D. & Voet, J. G. (2004). Biochemistry. New York: J. Wiley & Sons.
160. Vreugdenhil, E., Verissimo, C. S.L., Mariman, R., Kamphorst, J. T., Barbosa, J. S., Zweers, T., et al. (2009). MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: Implications for glucocorticoid responsiveness in the brain. Endocrinology, 150, 2220-2228.
161. Wallace, A. D. & Cidlowski, J. A. (2001). Proteasomemediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. Journal of Biological Chemistry, 276, 42714-42721.
162. Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., et al. (1985). Cloning of the human estrogen receptor cDNA. Proceedings of the National Academy of Sciences of the United States of America, 82, 7889-7893.
163. Waltering, K. K., Wallen, M. J., Tammela, T. L., Vessella, R. L., & Visakorpi, T. (2006a). Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer. The Prostate, 66, 1585-1591.
164. Waltering, K. K., Wallén, M. J., Tammela, T. L.J., Vessella, R. L., & Visakorpi, T. (2006b). Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer. The Prostate, 66, 1585-1591.
165. Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., et al. (2001a). Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. The Journal of Biological Chemistry, 276, 18375-18383.
166. Wang, H. B., Huang, Z. Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., et al. (2001b). Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science, 293, 853-857.
167. Webb, P., Nguyen, P., Shinsako, J., Anderson, C., Feng, W., Nguyen, M. P., et al. (1998). Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Molecular Endocrinology, 12, 1605-1618.
168. Wijayaratne, A. L. & McDonnell, D. P. (2001). The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. The Journal of Biological Chemistry, 276, 35684-35692.
169. Wilce, J. A., Leedman, P. J., & Wilce, M. C.J. (2002). RNAbinding proteins that target the androgen receptor mRNA. IUBMB Life, 54, 345-349.
170. Wu, R. C., Feng, Q., Lonard, D. M., & O'Malley, B. W. (2007). SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell, 129, 1125-1140.
171. Xu, W. T., Edmondson, D. G., & Roth, S. Y. (1998). Mammalian GCN5 and P/CAF acetyltransferases have homologous amino-terminal domains important for recognition of nucleosomal substrates. Molecular and Cellular Biology, 18, 5659-5669.
172. Yudt, M. R. & Cidlowski, J. A. (2002). The glucocorticoid receptor: Coding a diversity of proteins and responses through a single gene. Molecular Endocrinology, 16, 1719-1726.
173. Zhang, Y., Leung, D. Y., Nordeen, S. K., & Goleva, E. (2009). Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation. The Journal of Biological Chemistry, 284, 24542-24552.
174. Zhang, P.-J., Zhao, J., Li, H.-Y., Man, J.-H., He, K., Zhou, T., et al. (2007). CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome. The EMBO Journal, 26, 1831-1842.
175. Zhao, C., Dahlman-Wright, K., & Gustafsson, J. A. (2008a). Estrogen receptor beta: An overview and update. Nuclear Receptor Signaling, 6, e003.
176. Zhao, J.-J., Lin, J., Yang, H., Kong, W., He, L., Ma, X., et al. (2008b). MicroRNA-221/222 negatively regulates estrogen receptor{alpha} and is associated with tamoxifen resistance in breast cancer. The Journal of Biological Chemistry, 283, 31079-31086.
177. Zheng, L., Annab, L. A., Afshari, C. A., Lee, W. H., & Boyer, T. G. (2001). BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proceedings of the National Academy of Sciences of the United States of America, 98, 9587-9592.